What is precision medicine, and how is it different from standard of care treatment

April 3, 2026Navis AI

Ask Navis about your situation

This answer is general. Get one about your specific case — no signup, answered right here.

For informational purposes only

This answer was generated by AI grounded in NCCN guidelines and published medical literature. It is not medical advice. Always consult your oncologist or care team before making treatment decisions.

Sources & medical oversight

  • Developed under the medical oversight of OpenCancer’s physician-scientist team (Chris Apfel, MD/PhD/MBA, CMO · Kaumudi Bhawe, PhD, CSO).
  • Last updated April 3, 2026. Informational only — not a substitute for your oncology team.

Precision Medicine vs. Standard of Care Treatment

What Is Precision Medicine?

Precision medicine (also called personalized medicine) is an approach where treatment is tailored to the individual characteristics of each patient's cancer—rather than using a one-size-fits-all approach.

Instead of: "All patients with lung cancer get chemotherapy X"

Precision medicine asks: "What specific mutations does THIS patient's cancer have? What treatment will work best for THEIR tumor?"

How They Differ

| Standard of Care | Precision Medicine | |---|---| | Based on cancer type and stage | Based on cancer type, stage, AND genetic mutations | | Same treatment for most patients | Customized based on tumor biology | | Proven effective in large populations | Targeted to individual tumor characteristics | | Established, well-tested protocols | May include newer targeted drugs or combinations | | Often chemotherapy-based | Often includes targeted therapy or immunotherapy |

A Practical Example

Standard of Care for Stage 3 Lung Cancer: Chemotherapy + radiation therapy (proven effective for most patients)

Precision Medicine Approach:

  • Test shows EGFR mutation → Use EGFR inhibitor (targeted drug)
  • Test shows PD-L1 high expression → Use immunotherapy
  • Test shows KRAS mutation → Use KRAS inhibitor + chemotherapy
  • Test shows no actionable mutations → Standard chemotherapy may be best option

Why Precision Medicine Matters

According to NCCN Guidelines and ASCO recommendations, precision medicine can:

  1. Improve outcomes - Targeted drugs often work better than chemotherapy for specific mutations
  2. Reduce side effects - Targeted therapies may cause fewer side effects than broad chemotherapy
  3. Identify clinical trials - Genomic results can match you with trials testing new drugs for your specific mutation
  4. Avoid ineffective treatments - Skip drugs unlikely to work for your specific cancer

The Reality: It's Often Both

In modern oncology, standard of care increasingly includes precision medicine elements. Your doctor likely uses both:

  • Standard protocols as the foundation (proven, evidence-based)
  • Precision testing (genomic sequencing) to personalize within that framework
  • Targeted drugs when mutations are found that have FDA-approved treatments

According to the American Cancer Society, genomic testing is now standard practice for many cancer types, including:

  • Lung cancer
  • Breast cancer
  • Colorectal cancer
  • Melanoma
  • Leukemias and lymphomas

Questions to Ask Your Oncologist

  1. Is genomic testing recommended for my cancer type?
  2. What does "standard of care" mean for my specific diagnosis?
  3. Are there precision medicine options available for my cancer?
  4. If my tumor has specific mutations, what targeted treatments exist?
  5. Are there clinical trials I might be eligible for based on my tumor's genetics?

Important Context

Precision medicine isn't always "better"—it's different and individualized. Sometimes standard chemotherapy is the most effective option. Your oncologist will determine the best approach based on:

  • Your specific cancer type and stage
  • Available genomic test results
  • Your overall health
  • Proven effectiveness for YOUR situation

This information is for educational purposes only. Always consult your healthcare team for personalized medical advice and decisions.

Ask Navis about your case

That answer is general. Ask about your specific situation — no signup, answered right here.

Facing this with someone you love?

Keep the whole picture in one private place: records, a plain-language summary of where things stand, questions, and the people helping. Navis keeps it up to date so no one has to re-explain the story. Free, and only the people you invite can ever see it.

Start a care circle →

Related Questions

Prostate cancer, Gleason 6. Is active surveillance reasonable

TL;DR: Gleason 6 prostate cancer is generally considered low-risk, and active surveillance careful monitoring without immediate treatment is a reasona

What staging questions should I ask

TL;DR: Staging questions help your doctor understand how far your follicular lymphoma has spread, which directly determines your treatment options and

Just diagnosed with follicular lymphoma. What should I ask my oncologist

TL;DR: Follicular lymphoma is highly treatable, and your first conversation with your oncologist should focus on understanding your specific stage, wh

Prostate cancer, Gleason 6. Is active surveillance reasonable for me

TL;DR: Gleason 6 prostate cancer is generally considered low-risk, and active surveillance careful monitoring without immediate treatment is a reasona

What questions about staging should I bring up

TL;DR: Staging tells you how advanced your cancer is and helps your doctor plan treatment—ask your team to explain YOUR specific stage and what it mea

Just diagnosed with follicular lymphoma. What should I ask my oncologist at my first appointment

TL;DR: Your first appointment is about understanding your specific type of follicular lymphoma and what tests you need—ask your doctor what stage you

What lifestyle changes are recommended for cancer patients

TL;DR: Lifestyle changes like nutrition, exercise, sleep, and stress management can help support your body during cancer treatment and improve how you

What is the drug for fgfr mytation

Several FDA-approved drugs target FGFR mutations, with pemigatinib and infigratinib being the most commonly used; your doctor will choose based on you